Patents by Inventor Evan A. Stein

Evan A. Stein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS
    Publication number: 20210047434
    Abstract: The present invention relates to methods of treating or preventing cholesterol related disorders, such as hypercholesterolemia, hyperlipidemia or dyslipidemia, using antibodies against proprotein convertase subtilisin/kexin type 9 (PCSK9). Formulations and methods of producing said formulations are also described.
    Type: Application
    Filed: September 3, 2020
    Publication date: February 18, 2021
    Inventors: Joyce Chi Yee Chan, John P. Gibbs, Clapton S. Dias, Scott Wasserman, Robert Andrew Donald Scott, Christi L. Clogston, Timothy David Osslund, Evan A. Stein
  • METHODS FOR TREATING HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Publication number: 20150004174
    Abstract: The present invention relates to methods for treating homozygous familial hypercholesterolemia using antibodies against proprotein convertase subtilisin/kexin type 9 (PCSK9).
    Type: Application
    Filed: June 26, 2014
    Publication date: January 1, 2015
    Inventors: Scott Wasserman, Robert Andrew Donald Scott, Evan A. Stein
  • METHODS FOR TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS
    Publication number: 20140004122
    Abstract: The present invention relates to methods of treating or preventing cholesterol related disorders, such as hypercholesterolemia, hyperlipidemia or dyslipidemia, using antibodies against proprotein convertase subtilisin/kexin type 9 (PCSK9). Formulations and methods of producing said formulations are also described.
    Type: Application
    Filed: June 28, 2013
    Publication date: January 2, 2014
    Applicant: AMGEN INC.
    Inventors: Joyce Chi Yee CHAN, John P. GIBBS, Clapton S. DIAS, Robert Andrew Donald SCOTT, Evan A. STEIN, Scott WASSERMAN
  • Fluvastatin for the treatment of patients with a history of muscle related side effects with other statins
    Publication number: 20090275551
    Abstract: The present disclosure relates to method of using fluvastatin, alone or in combination with ezetimibe, be used to (1) lower cholesterol level, (2) treat hypercholesterolemia, (3) treat mixed dyslipidemia and/or (4) inhibit cholesterol biosynthesis in patients who experienced muscle-related side effects (MRSE). The present disclosure also relates to a pharmaceutical composition comprising ezetimibe and fluvastatin.
    Type: Application
    Filed: October 22, 2008
    Publication date: November 5, 2009
    Inventors: Evan A. Stein, Claudio Ruben Gimpelewicz